Online citations, reference lists, and bibliographies.
← Back to Search

Nanooncology: The Future Of Cancer Diagnosis And Therapy

A. Thakor, S. Gambhir
Published 2013 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
In recent years, there has been an unprecedented expansion in the field of nanomedicine with the development of new nanoparticles for the diagnosis and treatment of cancer. Nanoparticles have unique biological properties given their small size and large surface area‐to‐volume ratio, which allows them to bind, absorb, and carry compounds such as small molecule drugs, DNA, RNA, proteins, and probes with high efficiency. Their tunable size, shape, and surface characteristics also enable them to have high stability, high carrier capacity, the ability to incorporate both hydrophilic and hydrophobic substances and compatibility with different administration routes, thereby making them highly attractive in many aspects of oncology. This review article will discuss how nanoparticles are able to function as carriers for chemotherapeutic drugs to increase their therapeutic index; how they can function as therapeutic agents in photodynamic, gene, and thermal therapy; and how nanoparticles can be used as molecular imaging agents to detect and monitor cancer progression. CA Cancer J Clin 2013;63:395‐418. ©2013 American Cancer Society, Inc.
This paper references
10.1016/J.JCONREL.2004.11.023
In vitro and in vivo activities of verteporfin-loaded nanoparticles.
Y. Konan-Kouakou (2005)
10.1002/JBM.A.30781
Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI.
C. Sun (2006)
10.1038/nm879
Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation
E. Brown (2003)
10.1021/nn700040t
Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery.
Zhuang Liu (2007)
10.1021/bc9005283
Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
X. Wu (2010)
10.1155/2013/456409
Liposomal Doxorubicin in the Treatment of Breast Cancer Patients: A Review
J. Lao (2013)
Superparamagnetic iron oxide nanoparticleaptamer bioconjugates for combined prostate cancer imaging and therapy
AZ Wang (2008)
10.1002/chem.201000148
Advances in platinum chemotherapeutics.
Benjamin W. J. Harper (2010)
10.1002/adma.201002072
Remotely triggerable drug delivery systems.
B. P. Timko (2010)
Methotrexate-modified superparamagnetic nanoparticlesand their intracellularuptake intohuman cancercells.Langmuir.2005;21:8858-8864
N Kohler (2005)
10.1038/nnano.2008.231
Carbon nanotubes as photoacoustic molecular imaging agents in living mice.
A. de la Zerda (2008)
10.1097/mpa.0b013e3180439c50
Photodynamic Therapy for Pancreatic Cancer
B. Fan (2007)
10.1016/j.biomaterials.2011.08.086
Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy.
P. Huang (2011)
10.1021/LA0503451
Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells.
N. Kohler (2005)
10.1002/path.1027
The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies
L. Bingle (2002)
10.1038/nchem.480
A biocompatible condensation reaction for controlled assembly of nanostructures in live cells
Gaolin Liang (2010)
10.2174/138920012802850074
Nanoparticles improve biological functions of phthalocyanine photosensitizers used for photodynamic therapy.
Xiao Jia (2012)
10.1038/nrclinonc.2010.139
Delivering nanomedicine to solid tumors
R. Jain (2010)
10.1111/j.1365-2362.2010.02400.x
Potential clinical applications of siRNA technique: benefits and limitations
Shao-hua Chen (2011)
10.1039/b910000h
Effective photoreduction of a Pt(IV) complex with quantum dots: a feasible new light-induced method of releasing anticancer Pt(II) drugs.
Nina Gómez Blanco (2009)
10.1126/scitranslmed.3001963
The Fate and Toxicity of Raman-Active Silica-Gold Nanoparticles in Mice
A. Thakor (2011)
10.1016/j.ijpharm.2012.03.047
Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.
You Ling (2012)
10.2174/156720105774370159
Ligand-targeted liposomes for cancer treatment.
P. Sapra (2005)
10.1016/j.phrs.2010.01.009
Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds.
Pilar Rivera Gil (2010)
10.1016/j.addr.2008.08.003
Nanoparticles in photodynamic therapy: an emerging paradigm.
D. Chatterjee (2008)
10.1007/s00330-002-1721-7
Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
P. Reimer (2002)
10.1038/mt.2013.32
Phase I study of a systemically delivered p53 nanoparticle in advanced solid tumors.
N. Senzer (2013)
10.1016/j.jconrel.2012.10.007
Challenges and opportunities in the advancement of nanomedicines.
A. Wei (2012)
10.1016/j.ejpb.2010.12.029
Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration.
Stephanie Hirn (2011)
10.1007/s11095-010-0233-4
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
C. Oerlemans (2010)
10.1039/c0cc00667j
Synthesis of cRGD-peptide conjugated near-infrared CdTe/ZnSe core-shell quantum dots for in vivo cancer targeting and imaging.
K. Yong (2010)
10.1562/2005-12-14-RA-754
Determination of the Minimum Temperature Required for Selective Photothermal Destruction of Cancer Cells with the Use of Immunotargeted Gold Nanoparticles
X. Huang (2006)
10.1021/nn203895n
Photoacoustic sentinel lymph node imaging with self-assembled copper neodecanoate nanoparticles.
D. Pan (2012)
10.1002/smll.200900466
Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage.
Y. Pan (2009)
[Cationic liposomes in gene delivery].
T. Yotsuyanagi (1998)
10.1097/CCO.0b013e328351fb29
Clinical development of new formulations of cytotoxics in solid tumors
H. Azim (2012)
10.3322/CA.2007.0003
Application of Nanotechnology in Cancer Therapy and Imaging
X. Wang (2008)
10.3978/j.issn.2223-4292.2011.08.03
Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application.
Y. Wáng (2011)
10.2967/jnumed.107.043216
Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature
W. Cai (2007)
10.1016/S0939-6411(97)00150-1
Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.
A. Zur Mühlen (1998)
10.1038/sj.bjc.6602668
Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma
A. Toma (2005)
10.1158/1078-0432.CCR-10-2055
Noninvasive Radiofrequency Field Destruction of Pancreatic Adenocarcinoma Xenografts Treated with Targeted Gold Nanoparticles
Evan S Glazer (2010)
10.1016/j.ijpharm.2012.04.009
Folate-targeting magnetic core-shell nanocarriers for selective drug release and imaging.
H. Wang (2012)
10.1016/J.EURURO.2006.11.023
Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution.
M. Johannsen (2007)
10.1016/j.drudis.2012.03.010
Theranostic applications of nanoparticles in cancer.
Naveed Ahmed (2012)
10.1158/0008-5472.CAN-06-1668
Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.
Chunfu Zhang (2007)
10.1016/j.bmc.2009.02.043
Nanoparticles in cellular drug delivery.
A. H. Faraji (2009)
10.1007/BF02031373
On the physical rationale of laser induced hyperthermia
L. Svaasand (2005)
10.1016/J.BIOMATERIALS.2005.03.021
Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
Yuancai Dong (2005)
Poly(d,l-lactide-coglycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs
Y Dong (2005)
10.1166/JNN.2011.3094
Shape dependence of gold nanoparticles on in vivo acute toxicological effects and biodistribution.
Y. Sun (2011)
10.2165/11204910-000000000-00000
Mifamurtide: a review of its use in the treatment of osteosarcoma.
J. Frampton (2010)
10.1021/JA0680257
Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy.
S. Kim (2007)
10.1021/nn800330a
Uptake and intracellular fate of surface-modified gold nanoparticles.
P. Nativo (2008)
10.1002/ANIE.200501819
Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles.
S. Giri (2005)
Polymer nanoparticles: preparation techniques and size Nanooncology: The Future of Cancer Diagnosis and Therapy 414 CA: A Cancer Journal for Clinicians control parameters
JP Rao (2011)
FDA approves liposomal vincristine (Marqibo) for rare leukemia.
Ian Ingram (2012)
10.1016/J.PROGPOLYMSCI.2011.01.001
Polymer nanoparticles: Preparation techniques and size-control parameters
J. D. Rao (2011)
10.1016/B978-0-12-391860-4.00006-9
Multistage nanoparticles for improved delivery into tumor tissue.
T. Stylianopoulos (2012)
10.1016/J.MAM.2006.12.004
RNA interference: implications for cancer treatment.
M. Masiero (2007)
10.1016/S1470-2045(07)70150-X
Developmental biology, self-renewal, and cancer.
J. Niederhuber (2007)
10.1021/ar2000138
In vivo targeted delivery of nanoparticles for theranosis.
Heebeom Koo (2011)
10.1111/J.1751-1097.1998.TB02480.X
PhotochemCAD ‡ : A Computer‐Aided Design and Research Tool in Photochemistry
H. Du (1998)
Trastuzumab-dextran iron oxide nanoparticles
A. Chopra (2008)
10.1002/cbic.200800843
Shuttling Gold Nanoparticles into Tumoral Cells with an Amphipathic Proline‐Rich Peptide
S. Pujals (2009)
10.1016/J.EJRAD.2005.11.040
Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma.
A. Tanimoto (2006)
10.1038/nnano.2009.453
Properties and emerging applications of self-assembled structures made from inorganic nanoparticles.
Z. Nie (2010)
10.1016/j.biomaterials.2012.04.027
The preferential targeting of the diseased microvasculature by disk-like particles.
G. Adriani (2012)
10.1073/pnas.0710575105
Noninvasive molecular imaging of small living subjects using Raman spectroscopy
S. Keren (2008)
10.1016/j.biomaterials.2011.02.006
cRGD-functionalized, DOX-conjugated, and ⁶⁴Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging.
Xiaoqiang Yang (2011)
10.2147/IJN.S23348
In-vivo imaging of oral squamous cell carcinoma by EGFR monoclonal antibody conjugated near-infrared quantum dots in mice
K. Yang (2011)
10.1002/(SICI)1096-9896(1998110)186:3<262::AID-PATH191>3.0.CO;2-3
Aberrant type I and type III collagen gene expression in human breast cancer in vivo
S. Kauppila (1998)
10.1002/JPS.2600840420
Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system.
D. Bazile (1995)
10.1016/j.ijpharm.2008.10.003
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
J. Pardeike (2009)
10.1021/JA0386905
Semiconductor quantum dots for photodynamic therapy.
A. C. Samia (2003)
10.1016/j.biomaterials.2009.11.010
The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles.
Po-Wei Lee (2010)
10.1016/J.CPLETT.2008.08.039
Challenge in Understanding Size and Shape Dependent Toxicity of Gold Nanomaterials in Human Skin Keratinocytes.
Shuguang Wang (2008)
10.1016/S0163-7258(99)00073-X
Resistance mechanisms associated with altered intracellular distribution of anticancer agents.
A. Larsen (2000)
10.1016/S1040-8428(01)00179-2
The cellular and molecular basis of hyperthermia.
B. Hildebrandt (2002)
10.1021/nn300494k
Rapid size-controlled synthesis of dextran-coated, 64Cu-doped iron oxide nanoparticles.
Ray Wong (2012)
10.1016/j.biomaterials.2012.01.035
Gold nanomaterials conjugated with indocyanine green for dual-modality photodynamic and photothermal therapy.
Wen-Shuo Kuo (2012)
10.1002/CHIN.200914223
Noble Metals on the Nanoscale: Optical and Photothermal Properties and Some Applications in Imaging, Sensing, Biology, and Medicine
P. Jain (2009)
10.1002/anie.200805947
Molecular photoacoustic tomography with colloidal nanobeacons.
D. Pan (2009)
10.1093/ANNONC/MDM374
Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer.
D.-W. Kim (2007)
10.1016/S1470-2045(12)70476-X
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study.
C. Mamot (2012)
10.1177/1091581812465969
Evaluation of the Toxicity of Intravenous Delivery of Auroshell Particles (Gold–Silica Nanoshells)
S. Gad (2012)
10.1021/nl900031y
Mediating tumor targeting efficiency of nanoparticles through design.
Steven D. Perrault (2009)
10.2217/nnm.11.190
Nanoparticles as computed tomography contrast agents: current status and future perspectives.
M. Shilo (2012)
10.1016/J.CHEMBIOL.2006.11.015
The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.
Seungpyo Hong (2007)
10.1039/b923560d
Enhanced anticancer activity of multi-walled carbon nanotube-methotrexate conjugates using cleavable linkers.
Cristian Samorí (2010)
10.1007/BF01140804
Polyreaktionen —Mechanismen, Systematik, Relevanz
K. Geckeler (2005)
10.1016/j.pdpdt.2011.03.342
Photodynamic therapy (PDT) for lung cancer.
R. Allison (2011)
10.2165/00003088-200645120-00002
Pharmacology of Drugs Formulated with DepoFoam™
M. Angst (2006)
10.1038/nbt994
In vivo cancer targeting and imaging with semiconductor quantum dots
X. Gao (2004)
10.1016/J.ACRA.2004.04.018
Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery.
H. Choi (2004)
10.1002/(SICI)1097-0215(19980209)75:4<626::AID-IJC22>3.0.CO;2-5
Magnetic resonance imaging of esophageal squamous cell carcinoma using magnetite particles coated with anti‐epidermal growth factor receptor antibody
Toshikazu Suwa (1998)
10.1038/nrc1566
Cancer nanotechnology: opportunities and challenges
M. Ferrari (2005)
10.1038/nature08956
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
M. Davis (2010)
cRGDfunctionalized, DOX-conjugated, and (6)(4)Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging
X Yang (2011)
10.1021/JA046275M
A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent.
D. R. Radu (2004)
Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting.
K. Greish (2003)
10.1038/nnano.2009.314
Design considerations for tumour-targeted nanoparticles.
H. Choi (2010)
10.2214/AJR.152.1.167
Superparamagnetic iron oxide: pharmacokinetics and toxicity.
R. Weissleder (1989)
10.1155/2012/218940
Intracellular Delivery of siRNA by Polycationic Superparamagnetic Nanoparticles
B. Castillo (2012)
10.1586/ecp.11.7
Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review
A. Montero (2011)
10.1007/978-3-642-00477-3_2
Nanoparticle technologies for cancer therapy.
F. Alexis (2010)
10.1007/s10103-007-0470-x
Plasmonic photothermal therapy (PPTT) using gold nanoparticles
X. Huang (2007)
10.1023/A:1015587423262
Tumors and inflammatory infiltrates: Friends or foes?
Claudio Brigati (2004)
10.1016/j.addr.2012.06.012
Tumor-targeting multi-functional nanoparticles for theragnosis: new paradigm for cancer therapy.
Ju Hee Ryu (2012)
10.1007/s11060-005-9059-z
The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma
A. Jordan (2005)
Liposomal daunorubicin as treatment for Kaposi’s sarcoma
Christin E Petre (2007)
10.1016/j.nano.2011.08.017
Iron oxide nanoparticles for targeted cancer imaging and diagnostics.
Joshua E. Rosen (2012)
10.1089/CLM.1997.15.201
Two-photon photodynamic therapy.
J. D. Bhawalkar (1997)
MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis.
L. G. Remsen (1996)
10.1200/JCO.2012.43.7384
Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group.
G. Kaspers (2013)
10.1016/j.jconrel.2009.10.014
Size and shape effects in the biodistribution of intravascularly injected particles.
P. Decuzzi (2010)
10.1246/CL.2006.1046
Smart PEGylated Gold Nanoparticles for the Cytoplasmic Delivery of siRNA to Induce Enhanced Gene Silencing
Motoi Oishi (2006)
10.2147/IJN.S23696
Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy
E. Miele (2012)
10.1002/LSM.20223
Synergistic enhancement of selective nanophotothermolysis with gold nanoclusters: Potential for cancer therapy
V. Zharov (2005)
10.1700/1217.13491
Phase II trial of non-pegylated liposomal doxorubicin and low-dose prednisone in second-line chemotherapy for hormone-refractory prostate cancer.
M. Montanari (2012)
Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
P Reimer (2003)
Bethesda (MD): National Center for Biotechnology Information
(2004)
[Polyreactions--mechanisms, taxonomy, relevance].
K. E. Geckeler (1993)
10.1007/s10895-010-0772-4
Folate Conjugated CdHgTe Quantum Dots with High Targeting Affinity and Sensitivity for In vivo Early Tumor Diagnosis
Haiyan Chen (2010)
10.1039/b710915f
Rationally designed nanostructures for surface-enhanced Raman spectroscopy.
Matthew J. Banholzer (2008)
10.1049/iet-nbt.2010.0016
Comparison of quantum-dots- and fluorescein-isothiocyanate-based technology for detecting prostate-specific antigen expression in human prostate cancer.
Y. Ruan (2011)
10.1159/000059570
Transcatheter Arterial Embolization with Zinostatin Stimalamer for Hepatocellular Carcinoma
T. Okusaka (2002)
10.3390/ijms10020441
Quantum Dots for Live Cell and In Vivo Imaging
Maureen A. Walling (2009)
10.1007/s10637-012-9921-8
First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies
G. Weiss (2012)
Use of photodynamic therapy in malignant lesions of stomach, bile duct, pancreas, colon and rectum.
J. Wang (2007)
10.1021/mp900015y
The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic.
M. Davis (2009)
10.1016/S0169-409X(02)00044-3
Nanoparticles in cancer therapy and diagnosis.
I. Brigger (2002)
10.1097/JTO.0b013e31817c6b68
Randomized Phase III Trial Comparing Single-Agent Paclitaxel Poliglumex (CT-2103, PPX) with Single-Agent Gemcitabine or Vinorelbine for the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer
M. O'brien (2008)
10.1016/j.taap.2009.09.014
Effects and uptake of gold nanoparticles deposited at the air-liquid interface of a human epithelial airway model.
C. Brandenberger (2010)
Pancreatic cancer: are we moving forward yet? Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 20th, 2007.
M. Saif (2007)
10.1002/cmmi.455
Advanced contrast nanoagents for photoacoustic molecular imaging, cytometry, blood test and photothermal theranostics.
A. de la Zerda (2011)
10.3109/02656739709023559
Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.
A. Jordan (1997)
10.1158/0008-5472.CAN-08-1468
Drug delivery with carbon nanotubes for in vivo cancer treatment.
Zhuang Liu (2008)
10.1007/s10637-011-9757-7
Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum
J. Lee (2011)
10.1021/ja903300f
Porous hollow Fe(3)O(4) nanoparticles for targeted delivery and controlled release of cisplatin.
K. Cheng (2009)
10.1016/j.pdpdt.2011.01.001
Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinoma.
H. Quon (2011)
In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel
KY Win (2006)
10.1002/lsm.20968
Single‐wall carbon nanotubes assisted photothermal cancer therapy: Animal study with a murine model of squamous cell carcinoma
Naiyan Huang (2010)
10.1021/JA070461L
Nanoparticle self-assembly gated by logical proteolytic triggers.
G. von Maltzahn (2007)
10.1016/j.sder.2011.08.001
Photodynamic therapy: current evidence and applications in dermatology.
Y. Lee (2011)
10.1021/nn204352r
Family of enhanced photoacoustic imaging agents for high-sensitivity and multiplexing studies in living mice.
A. de la Zerda (2012)
10.1002/cmmi.454
Gold nanorods as molecular contrast agents in photoacoustic imaging: the promises and the caveats.
S. Manohar (2011)
Phase II trial of non-pegylated liposomal doxorubicin and low-dose prednisone in second-line chemotherapy for hormonerefractory prostate cancer
M Montanari (2012)
Metho - trexatemodified superparamagnetic nanoparticlesand their intracellularuptake intohuman cancercells
N Kohler (2005)
10.1023/B:BMMD.0000031747.05317.81
Molecular Imaging Applications in Nanomedicine
K. C. Li (2004)
10.1016/J.IJPHARM.2006.11.050
Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes.
S. Oliveira (2007)
10.1002/ADMA.201200420
Biologically responsive polymeric nanoparticles for drug delivery.
Y. Colson (2012)
10.2217/17435889.3.2.137
Theranostic nanomedicine for cancer.
B. Sumer (2008)
10.1016/S0169-409X(02)00179-5
Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities.
G. Saito (2003)
10.1016/j.ejca.2011.05.005
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer.
D. Amadori (2011)
10.1126/SCIENCE.1095833
Drug Delivery Systems: Entering the Mainstream
T. Allen (2004)
10.1111/j.1751-1097.1991.tb02071.x
DEFINITION OF TYPE I and TYPE II PHOTOSENSITIZED OXIDATION
C. Foote (1991)
10.1016/J.ADDR.2003.12.002
Solid lipid nanoparticles for parenteral drug delivery.
S. Wissing (2004)
10.1002/adma.201103521
Facile synthesis of monodisperse superparamagnetic Fe3O4 Core@hybrid@Au shell nanocomposite for bimodal imaging and photothermal therapy.
Wen-jie Dong (2011)
10.1517/17425247.2010.498816
Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery
Yannan Zhao (2010)
10.1002/cmdc.200800091
Superparamagnetic Iron Oxide Nanoparticle–Aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy
A. Wang (2008)
10.1080/02656730601175479
Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial
M. Johannsen (2007)
10.1096/fj.04-2747rev
Nanomedicine: current status and future prospects
S. Moghimi (2005)
10.1073/pnas.0810276106
Inferring clonal expansion and cancer stem cell dynamics from DNA methylation patterns in colorectal cancers
K. Siegmund (2009)
10.1038/nbt839
Noninvasive laser-induced photoacoustic tomography for structural and functional in vivo imaging of the brain
X. Wang (2003)
10.1016/j.biomaterials.2010.01.136
Near infrared photoacoustic detection of sentinel lymph nodes with gold nanobeacons.
D. Pan (2010)
10.1007/s10439-011-0472-5
Tunable Nanostructures as Photothermal Theranostic Agents
J. K. Young (2011)
10.1007/s11060-010-0389-0
Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme
K. Maier-Hauff (2010)
10.1002/MRM.1910400209
Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in Vivo by using transferrin receptor pathways
M. Kresse (1998)
10.1039/B707313E
Measuring the lifetime of singlet oxygen in a single cell: addressing the issue of cell viability.
S. Hatz (2007)
10.1021/NL070365I
Plasmonic nanosensors for imaging intracellular biomarkers in live cells.
S. Kumar (2007)
10.1021/AC061246A
Biological imaging of HEK293 cells expressing PLCgamma1 using surface-enhanced Raman microscopy.
S. Lee (2007)
The Nanomedicine Revolution: Part 2: Current and Future Clinical Applications
Ventola Cl (2012)
10.1016/j.ejrad.2009.01.042
Nanomedicine: perspective and promises with ligand-directed molecular imaging.
D. Pan (2009)
10.1021/nn200182x
Single-Walled Carbon Nanotubes Deliver Peptide Antigen into Dendritic Cells and Enhance IgG Responses to Tumor-Associated Antigens
C. Villa (2011)
10.1073/pnas.0813327106
Multiplexed imaging of surface enhanced Raman scattering nanotags in living mice using noninvasive Raman spectroscopy
C. Zavaleta (2009)
10.1089/0892779041271715
Evaluation of magnetic fluid hyperthermia in a standard rat model of prostate cancer.
M. Johannsen (2004)
10.1109/TUFFC.2007.435
Photoacoustic Imaging of Multiple Targets Using Gold Nanorods
P.-C. Li (2007)
10.1073/pnas.0914585107
Spatiotemporal controlled delivery of nanoparticles to injured vasculature
J. M. Chan (2010)
10.1006/MVRE.1996.0041
Effect of transvascular fluid exchange on pressure-flow relationship in tumors: a proposed mechanism for tumor blood flow heterogeneity.
P. A. Netti (1996)
10.1007/s00280-012-2042-4
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
J. Silverman (2012)
10.1038/nnano.2010.203
Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast
Jeyarama S. Ananta (2010)
10.1002/CHIN.201231239
Targeting Carbon Nanotubes Against Cancer
C. Fabbro (2012)
10.1016/S0378-5173(02)00452-0
Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery.
I. Roy (2003)
10.1073/pnas.0801763105
The effect of particle design on cellular internalization pathways
Stephanie E. A. Gratton (2008)
10.1126/SCIENCE.7512751
Requirement of vascular integrin alpha v beta 3 for angiogenesis.
P. Brooks (1994)
10.1002/anie.201008286
Gold-nanoshelled microcapsules: a theranostic agent for ultrasound contrast imaging and photothermal therapy.
Hengte Ke (2011)
10.1038/nnano.2006.170
In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice.
Z. Liu (2007)
10.1021/BC049951I
Toxicity of gold nanoparticles functionalized with cationic and anionic side chains.
Catherine M Goodman (2004)
Liposomes designed to avoid the reticuloendothelial system.
D. Papahadjopoulos (1990)
10.1016/j.jmgm.2010.11.002
How do carbon nanotubes serve as carriers for gemcitabine transport in a drug delivery system?
Uthumporn Arsawang (2011)
10.1002/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P
Design of folic acid-conjugated nanoparticles for drug targeting.
B. Stella (2000)
10.1016/J.BIOMATERIALS.2005.11.008
In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation.
K. Y. Win (2006)
10.1023/A:1011042627714
Incorporation of the Model Drug Ubidecarenone into Solid Lipid Nanoparticles
H. Bunjes (2004)
10.1073/pnas.1018382108
Multistage nanoparticle delivery system for deep penetration into tumor tissue
Cliff R. Wong (2011)
10.1634/THEONCOLOGIST.12-8-991
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).
P. Dinndorf (2007)
10.1016/S0168-3659(02)00127-X
Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake.
S. Sahoo (2002)
10.1021/ja211888a
Photoswitchable Nanoparticles for Triggered Tissue Penetration and Drug Delivery
R. Tong (2012)
10.1016/j.ijpharm.2010.05.008
Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Y. Liu (2010)
10.1021/JA028650L
A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules.
C. Lai (2003)
10.2217/nnm.11.155
Gold nanoprobes for theranostics.
B. Panchapakesan (2011)
10.1002/ANIE.200503389
Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway.
N. W. Kam (2006)
10.1146/ANNUREV.PHYSCHEM.54.011002.103759
Optical properties and ultrafast dynamics of metallic nanocrystals.
S. Link (2003)
10.1158/1078-0432.CCR-05-2831
Delivery of Telomerase Reverse Transcriptase Small Interfering RNA in Complex with Positively Charged Single-Walled Carbon Nanotubes Suppresses Tumor Growth
Zhuohan Zhang (2006)
An overview on preclinical and clinical experiences with photodynamic therapy for bladder cancer.
Nazila Yavari (2011)
10.1126/SCIENCE.281.5385.2016
Quantum dot bioconjugates for ultrasensitive nonisotopic detection.
W. C. Chan (1998)
10.1021/nn302042y
Photoacoustic imaging of mesenchymal stem cells in living mice via silica-coated gold nanorods.
J. Jokerst (2012)
10.1039/b815548h
Magnetic nanoparticles: synthesis, functionalization, and applications in bioimaging and magnetic energy storage.
N. Frey (2009)
10.1038/35888
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
A. Fire (1998)
Temozolo - mide loaded PLGAbased superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant gli
Y Ling (2012)
NUMBER 6 _ NOVEMBER/DECEMBER 2013 genetic interference by double-stranded RNA in Caenorhabditis elegans
(1998)
The nanomedicine revolution: part 2: current and future clinical applications.
C. Ventola (2012)
10.1126/scitranslmed.3003651
Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
Jeffrey Hrkach (2012)
10.1166/JBN.2012.1407
MR traceable delivery of p53 tumor suppressor gene by PEI-functionalized superparamagnetic iron oxide nanoparticles.
H. Lee (2012)
10.1016/S0168-3659(01)00324-8
Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy.
L. Xu (2001)
10.1172/JCI45600
Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma.
M. Benezra (2011)
10.1016/S1052-5157(03)00049-7
Photodynamic therapy in Barrett's esophagus.
K. Wang (2003)
Singlewalled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigens
CH Villa (2011)
10.1021/BC050050Z
Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments.
Fabio Sonvico (2005)
10.1002/CHEM.200500588
Hollow silica spheres with an ordered pore structure and their application in controlled release studies.
N. Botterhuis (2006)
10.1002/CHIN.200226275
Transferrin/transferrin receptor-mediated drug delivery.
H. Li (2002)
10.1016/S0065-2571(00)00013-3
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.
H. Maeda (2001)
10.1021/BC050033+
Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus.
J. M. de la Fuente (2005)
10.2174/157340711795163866
CRLX101 (formerly IT-101)–A Novel Nanopharmaceutical of Camptothecin in Clinical Development
C. Young (2011)
10.1038/nrd2742
Knocking down barriers: advances in siRNA delivery
K. Whitehead (2009)
10.1038/nm.2721
A Brain Tumor Molecular Imaging Strategy Using A New Triple-Modality MRI-Photoacoustic-Raman Nanoparticle
M. Kircher (2012)
10.3109/02656739309061478
Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia.
A. Jordan (1993)
10.1002/adma.201201251
Core-shell nanocapsules stabilized by single-component polymer and nanoparticles for magneto-chemotherapy/hyperthermia with multiple drugs.
S. Hu (2012)
10.1038/srep01293
Photothermal nanodrugs: potential of TNF-gold nanospheres for cancer theranostics
Jingwei Shao (2013)
10.1093/ANNONC/MDH092
Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer.
Y. Matsumura (2004)
10.1517/17425247.2013.758631
Hyperthermia-induced drug targeting
Jonathan P. May (2013)
netic nanoparticles : synthesis , functionalization , and applications in bioimaging and magnetic energy storage
NA Frey (2010)
Potent and specific CA CANCER
A Fire (2013)
10.1016/j.cell.2007.04.037
Molecular Basis for Target RNA Recognition and Cleavage by Human RISC
Stefan L. Ameres (2007)
10.1038/nrc1256
Tumour-educated macrophages promote tumour progression and metastasis
J. Pollard (2004)
10.2147/IJN.S596
Drug delivery and nanoparticles: Applications and hazards
W. D. de Jong (2008)
Polyreactions–mechanisms, taxonomy, relevance [in German
KE Geckeler (1993)
10.1016/S0142-9612(01)00125-9
The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides
T. Chirila (2002)
10.1016/j.jconrel.2012.03.020
Doxil®--the first FDA-approved nano-drug: lessons learned.
Y. Barenholz (2012)
10.2174/1567201043334768
Targeting intracellular targets.
J. Panyam (2004)
10.1002/lsm.21104
Photodynamic therapy for prostate cancer—an emerging approach for organ‐confined disease
C. Moore (2011)
Transport of molecules in the tumor interstitium: a review.
R. Jain (1987)
Kaposi's sarcoma: DaunoXome approved.
(1996)



This paper is referenced by
Cancer Nanotechnology: Hopes and Hurdles
Syed Abdul Kuddus (2017)
10.1039/c4nr00241e
Surface plasmon resonance mediated photoluminescence properties of nanostructured multicomponent fluorophore systems.
Saji Thomas Kochuveedu (2014)
10.1016/J.COCHE.2014.02.001
Intelligent recognitive systems in nanomedicine.
Heidi R Culver (2014)
10.1016/J.JPHOTOCHEM.2018.06.025
Oxidation-reduction processes in CeO2-x nanocrystals under UV irradiation
V. Klochkov (2018)
10.1007/978-3-030-04861-7_13
Nanomedicine in Gastric Cancer
Nayla Mouawad (2019)
10.1021/acsami.8b09098
pH- and Enzyme-Sensitive IR820-Paclitaxel Conjugate Self-Assembled Nanovehicles for Near-Infrared Fluorescence Imaging-Guided Chemo-Photothermal Therapy.
D. Zhang (2018)
10.2174/1568026615666150414123157
Active Targeted Drug Delivery for Microbes Using Nano-Carriers
Y. Lin (2015)
10.1016/j.jphotobiol.2015.03.007
Integrative approach in prevention and therapy of basal cellular carcinoma by association of three actives loaded into lipid nanocarriers.
G. Badea (2015)
10.1002/smll.201403248
Reversibly extracellular pH controlled cellular uptake and photothermal therapy by PEGylated mixed-charge gold nanostars.
S. Wang (2015)
10.1016/j.msec.2017.07.040
Development and characterization of miltefosine-loaded polymeric micelles for cancer treatment.
Johanna Karina Valenzuela-Oses (2017)
10.1007/978-81-322-2175-3_2
Natural and Semisynthetic Nanoparticles in Lung Cancer Diagnosis and Therapy
A. Bandyopadhyay (2015)
10.3390/mi8010010
Preparation of Protein Nanoparticles Using NTA End Functionalized Polystyrenes on the Interface of a Multi-Laminated Flow Formed in a Microchannel
H. J. Jeon (2017)
10.1016/j.canlet.2015.01.013
The redox-active nanomaterial toolbox for cancer therapy.
Irene L. Ibañez (2015)
10.1021/acsnano.7b07757
Adjuvant Photothermal Therapy Inhibits Local Recurrences after Breast-Conserving Surgery with Little Skin Damage.
S. Wang (2018)
10.18632/oncotarget.13431
Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma
Huiying Xue (2016)
10.1016/B978-0-323-47347-7.00024-0
Iron Oxide Nanoparticles for Cancer Diagnosis and Therapy
M. Marciello (2016)
10.1364/JOT.81.000444
Investigation of biocompatible complexes of Mn 2+ -doped ZnS quantum dots with chlorin e6
A. Visheratina (2014)
10.1002/smll.201907322
Cerium Oxide Nanoparticles: Advances in Biodistribution, Toxicity, and Preclinical Exploration.
E. Casals (2020)
10.1016/J.MATTOD.2015.07.004
Inorganic nanoparticles for biomedicine: where materials scientists meet medical research
J. J. Giner-Casares (2016)
10.3389/fphy.2018.00047
Hybrid Imaging: Instrumentation and Data Processing
J. Cal-Gonzalez (2018)
10.3389/fchem.2014.00112
Molecular imaging of breast cancer: present and future directions
D. Alcántara (2014)
10.2967/jnumed.114.146019
Theranostic Nanoparticles
F. Chen (2014)
10.1117/12.2061379
Feedback-mediated cancer therapy: a FRET-based nanoreporter approach
Suproteem K. Sarkar (2014)
10.2147/IJN.S65817
Gold nanoparticles prepared by laser ablation in aqueous biocompatible solutions: assessment of safety and biological identity for nanomedicine applications
F. Correard (2014)
10.14478/ACE.2017.1039
Research Trends in Photothermal Therapy Using Gold Nanoparticles
Bong-Geun Kim (2017)
10.1016/j.biopha.2014.07.015
Biocompatibility and biodistribution of suberoylanilide hydroxamic acid loaded poly (DL-lactide-co-glycolide) nanoparticles for targeted drug delivery in cancer.
R. Sankar (2014)
10.7282/T3-B3AG-ZZ33
Transport and deposition of nanoparticles in microvascular networks
Hassan M. Al-Siraj (2019)
10.1039/c8nr08790c
Non-invasive and quantitative in vivo monitoring of gold nanoparticle concentration and tissue hemodynamics by hybrid optical spectroscopies.
M. Mireles (2019)
10.5483/BMBRep.2018.51.1.237
Integration of metabolomics and transcriptomics in nanotoxicity studies
T. H. Shin (2018)
Cancer Nanotechnology Plan 2015
M. Davis (2015)
10.1007/978-81-322-2175-3
Nanoparticles in Lung Cancer Therapy - Recent Trends
A. Bandyopadhyay (2014)
10.1016/J.PMATSCI.2020.100743
MOF materials as therapeutic agents, drug carriers, imaging agents and biosensors in cancer biomedicine: Recent advances and perspectives
A. Bieniek (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar